Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01762813

Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Colorectal Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases Rectal Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Stavanger University Hospital

Stavanger, 4068, Norway

Location status: Recruiting

Location contact

Kjetil Søreide, MD, PhD

CONTACT

[email protected]

92281557 ext. 47

Kjetil Søreide, MD, PhD

PRINCIPAL_INVESTIGATOR

About this study

Prospective project in collecting and assessing clinical outcomes data related to molecular profiling of tumors based on cancer primary or metastatic tissue or tissue from peripheral blood samples. As a future part of the project will be collected patient reported outcomes (PROs) for assessing clinical outcomes in relation to clinical pathways, patient reported results, as well as tumor profiling by molecular methods.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery
  • Informed consent to participate
  • Age ≥18

Exclusion criteria

  • failure to provide written informed consent

Treatment and study plan

open and laparoscopic surgery

Procedure

Curative surgery for either primary (colorectal cancer, crc) or metastatic CRC (liver surgery)

Other names: Liver surgery

Primary outcomes

  1. Cancer-specific survival

    Time frame: 5-years

    Time from surgery to death of cancer

Secondary outcomes

  1. Recurrence-free survival

    Time frame: 3 and 5 years

    Time from surgery to recurrence of cancer

Study contacts

Contact information is provided by the study sponsor or research team.

Marina Alexeeva, PhD

CONTACT

[email protected]

Ramesh L. Kajavi, RN

CONTACT

[email protected]

92297672 ext. 47

Sponsors and collaborators

Lead sponsor

Helse Stavanger HF

Other Gov

Registry information

Official study title

Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer

Acronym: ACROBATICC

Important dates

Study start
2013
Primary completion
2035
Study completion
2036
First posted
Jan 8, 2013
Registry last updated
Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.